Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Scanfil Q3’23: No Surprises

Scanfil

The overall picture of Scanfil’s Q3 report was somewhat neutral relative to the lowered expectations, as the result was in line with our expectations and the report did not dispel the uncertainty surrounding next year’s outlook. Head of Research Antti Viljakainen comments in an interview.

Content:
00:00 Intro
00:12 Q3 in a nutshell
01:18 Estimates
01:48 Market situation and comparison to peers
02:36 Market sentiment
03:33 Valuation 
05:00 Institutional ownership 

Stay up to date
Analyst Interviews

Recent videos

Lundbeck - Gennemgang af investment casen
09.03.2026, 16.00 Lundbeck
Scanfil Q4’25: Horizontal operational progress
09.03.2026, 10.26 Scanfil
HCA Morgenbørs 06/03 - Investorerne finder lidt ro efter en uge præget af usikkerhed
06.03.2026, 09.25 Zealand Pharma
Aiforia, Webcast, H2, 2025
06.03.2026, 09.00 Aiforia Technologies
Nightingale, Webcast, Half-year financial report 1 July–31 December 2025
05.03.2026, 13.00 Nightingale Health
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.